This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Author: Avi Kapoor | April 09, 2025 08:32am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Keybanc analyst Paul Knight downgraded the rating for Bio-Techne Corporation (NASDAQ:TECH) from Overweight to Sector Weight. Bio-Techne shares closed at $48.81 on Tuesday. See how other analysts view this stock.
HC Wainwright & Co. analyst Mitchell Kapoor downgraded Rallybio Corporation (NASDAQ:RLYB) from Buy to Neutral. Rallybio shares closed at $0.25 on Tuesday. See how other analysts view this stock.
Evercore ISI Group analyst Elizabeth Anderson downgraded the rating for Health Catalyst, Inc. (NASDAQ:HCAT) from Outperform to In-Line and lowered the price target from $6 to $4. Health Catalyst shares closed at $3.82 on Tuesday. See how other analysts view this stock.
Jefferies analyst David Katz downgraded Host Hotels & Resorts, Inc. (NASDAQ:HST) from Buy to Hold and cut the price target from $20 to $14. Host Hotels & Resorts shares closed at $12.70 on Tuesday. See how other analysts view this stock.
JP Morgan analyst Alexei Gogolev downgraded the rating for PTC Inc. (NASDAQ:PTC) from Overweight to Neutral and lowered the price target from $210 to $160. PTC shares closed at $136.74 on Tuesday. See how other analysts view this stock.
Considering buying PTC stock? Here’s what analysts think:
